Maurice Hilleman/Merck Award
ASM’s premier award for major contributions to pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases. The award is presented in memory of Maurice R. Hilleman, whose work in the development of vaccines has saved the lives of many throughout the world.
Maurice Hilleman/Merck Award Eligibility:
The nominee must have made outstanding achievements in pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases.
A cash prize of $20,000, a commemorative piece, and travel to the ASM General Meeting where the laureate will deliver the Maurice Hilleman/Merck Award lecture.
Deadline: July 1.
Nominations will be considered without updating for three years. Self-nominations and more than one nomination per nominee will not be accepted. Only one nominating form and two supporting forms are accepted per nomination. The two supporters must be persons other than the nominator who are familiar with the nominee's qualifications and accomplishments. Only one of the three individuals involved in the nomination may be employed at the nominee's institution. The nominator and supporters must not share employers. Nominations must consist of the following:
Curriculum vitae, including a list of publications, emailed to email@example.com
ASM awards are granted at the discretion of the award selection committees and may not be awarded every year.
Sponsor: Merck & Co., Inc.